1.
Bektur C, Nurgozhin T. Cost-effectiveness Analysis of Denosumab in the Prevention of Skeletal-related Events in Patients with Prostate Cancer in Kazakhstan. cajgh [Internet]. 2014 Dec. 12 [cited 2022 Aug. 17];3. Available from: http://cajgh.pitt.edu/ojs/cajgh/article/view/154